Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C28H22NO6P |
| Molecular Weight | 499.4511 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1C2=C3C(=CN2CC4=CC=CC=C14)C(=O)C5=C(OP(O)(=O)OCC6=CC=CC=C6)C=CC=C5C3=O
InChI
InChIKey=UXTSQCOOUJTIAC-UHFFFAOYSA-N
InChI=1S/C28H22NO6P/c1-17-20-11-6-5-10-19(20)14-29-15-22-25(26(17)29)27(30)21-12-7-13-23(24(21)28(22)31)35-36(32,33)34-16-18-8-3-2-4-9-18/h2-13,15,17H,14,16H2,1H3,(H,32,33)
| Molecular Formula | C28H22NO6P |
| Molecular Weight | 499.4511 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Fosquidone (also known as GR63178A), a pentacyclic pyrroloquinone that was developed as an anticancer agent. Fosquidone participated in phase II clinical trial for the treatment of patients with colorectal, renal and non-small cell lung cancer. However, the drug didn’t show significant antitumor activity. The further development of this drug was discontinued.
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Stability of GR63178A, a novel pentacyclic pyrroloquinone anticancer compound, in aqueous solutions and biological fluids. | 1993-01 |
|
| Phase I study of intravenous fosquidone (GR63178A-NSC D611615) using a three times a week schedule. | 1992-05 |
|
| Phase II trials of fosquidone, (GR63178A), in colorectal, renal and non-small cell lung cancer. CRC Phase II Clinical Trials Committee. | 1992-04 |
|
| Activity of GR30921X (NSC 382057) and GR63178A (NSC D611615) in human ovarian cancer lines. | 1990-05 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1314072
The drug was given intravenously as a 20 min infusion at the dose of 120 mg-2 on days 1 to 5 every 3 weeks.
Route of Administration:
Intravenous
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 09:27:56 GMT 2025
by
admin
on
Wed Apr 02 09:27:56 GMT 2025
|
| Record UNII |
FD6QP9BP8U
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C274
Created by
admin on Wed Apr 02 09:27:56 GMT 2025 , Edited by admin on Wed Apr 02 09:27:56 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
CHEMBL2009105
Created by
admin on Wed Apr 02 09:27:56 GMT 2025 , Edited by admin on Wed Apr 02 09:27:56 GMT 2025
|
PRIMARY | |||
|
114517-02-1
Created by
admin on Wed Apr 02 09:27:56 GMT 2025 , Edited by admin on Wed Apr 02 09:27:56 GMT 2025
|
PRIMARY | |||
|
CC-83
Created by
admin on Wed Apr 02 09:27:56 GMT 2025 , Edited by admin on Wed Apr 02 09:27:56 GMT 2025
|
PRIMARY | |||
|
C072687
Created by
admin on Wed Apr 02 09:27:56 GMT 2025 , Edited by admin on Wed Apr 02 09:27:56 GMT 2025
|
PRIMARY | |||
|
C1371
Created by
admin on Wed Apr 02 09:27:56 GMT 2025 , Edited by admin on Wed Apr 02 09:27:56 GMT 2025
|
PRIMARY | |||
|
SUB07806MIG
Created by
admin on Wed Apr 02 09:27:56 GMT 2025 , Edited by admin on Wed Apr 02 09:27:56 GMT 2025
|
PRIMARY | |||
|
71328
Created by
admin on Wed Apr 02 09:27:56 GMT 2025 , Edited by admin on Wed Apr 02 09:27:56 GMT 2025
|
PRIMARY | |||
|
100000080443
Created by
admin on Wed Apr 02 09:27:56 GMT 2025 , Edited by admin on Wed Apr 02 09:27:56 GMT 2025
|
PRIMARY | |||
|
DTXSID00921408
Created by
admin on Wed Apr 02 09:27:56 GMT 2025 , Edited by admin on Wed Apr 02 09:27:56 GMT 2025
|
PRIMARY | |||
|
FD6QP9BP8U
Created by
admin on Wed Apr 02 09:27:56 GMT 2025 , Edited by admin on Wed Apr 02 09:27:56 GMT 2025
|
PRIMARY | |||
|
6520
Created by
admin on Wed Apr 02 09:27:56 GMT 2025 , Edited by admin on Wed Apr 02 09:27:56 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ENANTIOMER -> RACEMATE | |||
|
|
ENANTIOMER -> RACEMATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |